Diagnostic Cytology of the Liver


As the role of fine-needle aspiration biopsy (FNAB) in the evaluation of focal liver lesions has evolved, it has presented new challenges. Advances in dynamic imaging modalities have obviated the need for tissue confirmation in clinically classic cases of hepatocellular carcinoma (HCC). Ultrasound surveillance and serum α-fetoprotein (AFP) assessment of high-risk patients have improved the detection of small nodules (≤2 cm in diameter). Accurate cytohistologic characterization of small, well-differentiated hepatocellular nodules on limited tissue samples is extremely challenging, but it has important therapeutic implications.

Much progress has been made in the molecular characterization of tumors by genomic, microRNA, and proteomic methods. There are promising new tools for tumor diagnosis, for predicting the prognosis and progression of disease, and for personalized, molecularly targeted anticancer therapies and chemopreventive strategies. Because FNAB is the least invasive tool for tissue procurement, it is predicted that it will become a point of care in the management algorithm of HCC for diagnostic, therapeutic, and prognostication purposes.

Use of Fine-Needle Aspiration Biopsy

Guidance Systems

Percutaneous (transabdominal) FNAB performed under ultrasound or computed tomography (CT) guidance is a safe, efficacious, and cost-effective outpatient procedure for the diagnosis of focal liver lesions. Aspiration can also be performed during laparotomy or laparoscopy under palpation or direct vision. Endoscopic ultrasound-guided FNA (EUS-FNA) is the latest diagnostic and staging tool and is used primarily for left hepatic lobe lesions and hilar or perihilar masses, in which the needle traverses the wall of the gastrointestinal tract. Factors influencing the choice of guidance system include the size and location of the lesion, operator expertise and preference, and availability of imaging technologies.

Ultrasound provides rapid localization, flexible patient positioning, and imaging of the lesion without radiation. It is typically used for initial guidance, particularly when there are multiple lesions or large, relatively superficial lesions. CT allows optimal resolution of small lesions or lesions not visible with ultrasound, accurate localization of the needle tip immediately before sampling, improved definition of tissue components and vascularity, and more precise demonstration of the anatomic relationships of a given lesion.

EUS-FNA is a safe, accurate, and versatile technique, but it is highly operator dependent. It allows concurrent sampling of pancreas and liver lesions, which can confirm primary and metastatic lesions in one diagnostic encounter. The technique is useful for small and deep-seated left lobe lesions that are below CT or magnetic resonance imaging (MRI) resolution or lesions that are not easily accessible by percutaneous FNAB. It improves staging of liver metastases, is good for early detection of multifocal HCC in cirrhosis, and can assess the accurate number of lesions (e.g., intrahepatic staging of HCC) for transplantation eligibility.

Percutaneous FNAB techniques include individual puncture , coaxial biopsy, and tandem needle biopsy techniques. Multiple aspirations (as many as four passes) usually can be performed with minimal morbidity. The needle size is between 20 and 22 gauge. Aspiration needles with a guillotine mechanism enable microbiopsy cores to be procured at the same sitting. Concomitant core-needle (18-gauge) biopsies may also be performed.

Indications and Contraindications

FNAB is the diagnostic procedure of choice for focal liver lesions, especially to confirm a suspected malignancy ( Box 45.1 ). It is particularly advantageous for advanced malignancies and patients who are poor surgical candidates. Another indication is drainage of a cyst or abscess for culture and therapeutic ablation. Early affirmative diagnosis leads to cost savings in terms of further investigational tests and hospitalization.

Box 45.1

Fine-Needle Aspiration Biopsy of the Liver

Indications, Contraindications, and Complications

  • Indications

    • Evaluating a mass or cystic lesion

    • Draining a cyst or abscess

  • Contraindications

    • Uncorrectable bleeding diathesis

    • Lack of safe access route

    • Uncooperative patient

    • Intestinal obstruction (for endoscopic ultrasound-guided fine-needle aspiration biopsy)

  • Complications

    • Bleeding

    • Needle tract seeding

    • Tumor recurrence and posttransplantation tumor recurrence

Contraindications for percutaneous FNAB include an uncorrectable bleeding diathesis, lack of a safe access route (i.e., biopsy through a vascular structure), and an uncooperative patient for whom awkward positioning or maintenance of strict breath control is necessary to ensure proper needle placement. For EUS-FNA, gastrointestinal obstruction is an absolute contraindication resulting from the risk of perforation.


Complications of FNAB are uncommon. There may be bleeding, which is mostly associated with severe cirrhosis and coagulopathy but may relate to the size of needle used, particularly in vascular lesions and in large superficial tumors not covered by normal parenchyma (see Box 45.1 ). Needle tract seeding is rare, with an incidence of 0.003% to 0.009% for malignancy in general and 0.003% to 5% for HCC; if a small (22-gauge), noncutting needle is used, the rate for HCC is approximately 0.11%. A higher incidence of HCC recurrence in the transplanted liver has been reported in transplantation cases with preoperative FNAB. Death, usually resulting from bleeding, is rare, with a reported mortality rate of 0.018%.

Clinical Considerations

There is much debate regarding the use of preoperative FNAB for the diagnosis of HCC. Several reasons are cited for opposing FNAB:

  • Advances in dynamic imaging modalities that are sufficiently sensitive for establishing an HCC diagnosis

  • Risk of needle tract seeding

  • Risk of intraperitoneal bleeding

  • Risk of intraprocedural hematogenous dissemination, which results in a higher incidence of tumor and posttransplantation recurrence

  • Adoption of a wait and see policy for hepatocellular nodules that are less than 1 cm in diameter

  • Indeterminate cytohistologic reports rendered for well-differentiated hepatocellular nodules

Several reasons are cited for favoring FNAB:

  • Serum AFP has a low sensitivity (<50%)

  • Use of the coaxial biopsy technique to reduce the risk of seeding

  • Decreased costs of long-term imaging surveillance

  • Avoiding futile transplantation in false-positive imaging cases

  • Allaying patient anxiety after a liver nodule has been detected on imaging

  • Confirmation of HCC that increases eligibility for liver transplantation

  • Immediate institution of anti-HCC therapy when the lesion is less than 2 cm in diameter

According to the European Association for the Study of the Liver (EASL) 2000 Conference and the American Association for the Study of Liver Disease (AASLD) guidelines, nodules more than 2 cm in diameter in cirrhotic livers are diagnosed as HCC if they show an intense arterial profile with contrast washout in delayed venous phase on one dynamic imaging modality. Nodules between 1 and 2 cm in cirrhotic livers require concurrence of two coincidental imaging modalities; otherwise, biopsy is recommended. For nodules less than 1 cm in diameter, the EASL guidelines recommend a wait and see policy with surveillance every 3 months. Approximately 68% of nodules less than 1 cm in diameter in cirrhotic livers are HCCs. In skilled hands and with an expert reader, ultrasound-guided FNAB of hepatic nodules less than 1 cm in diameter can yield correct diagnoses in 90% of cases. The conundrum is to balance the risk of unnecessary surgery (2.5%) against the risk of seeding.

Specimen Preparation

The types of small tissue samples from liver FNAB include direct smears, needle rinses, core imprints, cell blocks, microbiopsies, and core-needle biopsies. Smears may be air-dried and stained with Diff-Quik or May-Grünwald-Giemsa or fixed in 95% alcohol and stained by the Papanicolaou method. Rapid touch preparations (imprints) can be performed to assess the adequacy of tissue cores. If well-fixed, adequately smeared slides are difficult to obtain, the aspirate can be expressed into a preservative and submitted as a liquid-based specimen for processing by the ThinPrep or SurePath method.

Cell blocks are made from needle rinses and tissue fragments. Particulate material should be quickly retrieved from the glass slides before staining for subsequent formalin-fixed, paraffin-embedded cell block preparation. Histologic sections allow for architectural appraisal, special stains, and immunohistochemistry. Immunocytochemistry may be necessary if only smears are available.

Diagnostic Accuracy

The prerequisites for optimal results with FNAB are listed in Box 45.2 . The sensitivity of FNAB varies according to the method used (i.e., blind versus guided aspiration, number of passes, and operator skill), characteristics of the lesion (size, location, and consistency), and standard of cytopathology service (e.g., quality of smears, combined cytohistologic analysis, ancillary testing, reader expertise). On-site cytology service may provide rapidly stained smears for evaluation of sample adequacy, retrieval of particulate material for cell block preparation, and triage of specimens for culture, flow cytometry, electron microscopy, and other ancillary tests, including molecular studies. In the absence of an on-site service, it is imperative that the aspirator learns how to make proper smears and that a tissue management protocol is clearly understood by the patient care team.

Box 45.2

Prerequisites for Optimal Fine-Needle Aspiration Biopsy Results

  • Dedicated and experienced aspirator and reader team

  • On-site cytology service to assess specimen adequacy, retrieve material for cell blocks, and triage specimen for microbiologic studies, flow cytometry, electron microscopy, molecular analysis, and other ancillary tests

  • Combined cytohistologic approach

  • Judicious use of immunohistochemistry

  • Clinicopathologic correlation

The sensitivity and specificity of percutaneous FNAB for detection of liver malignancy are about 90% (range, 67% to 100%) and 100%, respectively. The positive and negative predictive values and overall accuracy of FNAB diagnosis for liver malignancy were reported in one large study to be 100%, 59.1%, and 92.4%, respectively. EUS-FNA also has a high sensitivity (82% to 94%) and specificity (90% to 100%) for malignancy. Similar to percutaneous FNAB, EUS-FNA leads to a better diagnostic yield with metastases compared with well-differentiated hepatocellular tumor nodules. False positives are rare. False-negative diagnoses are most often the result of a sampling error because of inexact needle localization related to small masses, large areas of necrosis, fibrosis, or a prominent inflammatory rim. The supplemental nature of FNAB and concomitant core-needle biopsy improve overall accuracy, especially for benign neoplasms and poorly differentiated neoplasms that require ancillary studies.

Liquid-based cytology of liver aspirates shows good correlation with conventional smears and reduces false-negative diagnoses. Advantages include more representative sampling and better cell preservation. Disadvantages include no on-site assessment of adequacy or triage of specimens, no air-dried smears for Giemsa preparations, removal of background elements, high cost, and the need for familiarity with cytologic artifacts and recognition of diagnostic pitfalls to avoid misinterpretations. In our experience (unpublished data) with the ThinPrep method, the cytologic features of HCC appear to be rather nondifferentiated. Cytoarchitectural features, such as arborizing trabecular structures, pseudoacinar rosettes, and peripheral or transgressing endothelium, are less evident or completely lost. Tumor aggregates tend to be tighter, three dimensional, and smaller. Cells are usually smaller with nondescript shapes and denser cytoplasm, and they often have frayed borders.

Diagnostic Issues

Focal liver lesions range from cystic and inflammatory or infectious entities to benign or malignant primary and metastatic neoplasms. HCC is well known for its heterogeneity. Intrahepatic cholangiocarcinoma (CC) frequently shows nondescript features of adenocarcinoma. The liver is a common depository for metastases. Given these permutations, primary liver carcinomas can mimic many tumors and vice versa. The diagnostic issues are listed in Box 45.3 .

Box 45.3

Diagnostic Issues in the Evaluation of Focal Liver Lesions

  • Differentiating well-differentiated hepatocellular nodules from reactive hepatocytes

  • Distinguishing various types of benign, well-differentiated hepatocellular nodules

  • Differentiating early, well-differentiated hepatocellular carcinoma from benign hepatocellular nodules

  • Recognizing hepatocellular carcinoma and its variants from their mimics

  • Differentiating poorly differentiated hepatocellular carcinoma from intrahepatic cholangiocarcinoma

  • Differentiating intrahepatic cholangiocarcinoma from metastatic adenocarcinoma

  • Differentiating poorly differentiated primary liver carcinomas from metastases

  • Determining the histogenesis of nonhepatocellular tumors

  • Determining the primary site of origin of malignant nonhepatocellular tumors

  • Differentiating benign and malignant cystic lesions

  • Recognizing inflammatory or infectious lesions that may mimic tumors

Integrative Approach to the Evaluation of Liver Aspirates

A stepwise algorithmic approach to evaluating liver aspirates includes full clinicopathologic correlations ( Box 45.4 ):

  • 1.

    Evaluate clinical information. A patient may be seen with one or more focal liver lesions in the following scenarios: routine medical checkup, screening or surveillance of chronic liver disease, follow-up of a known cancer case, investigation of a symptomatic patient, or investigation of a pediatric lesion. Relevant clinical findings, liver function profile, serology, and tumor markers should be obtained.

  • 2.

    Evaluate radiologic information. Focal liver lesions may be cystic or solid and single or multiple. The presence of preexisting or chronic hepatobiliary disease and associated radiologic findings should be determined. Advances in dynamic contrast-enhanced imaging modalities have increased the sensitivity and specificity for detection of classic HCC. Siderotic nodules are readily detected on T2- or T2*-weighted MRI.

  • 3.

    Evaluate cytohistologic findings. The smears are scanned at low power to establish the pattern and architecture before close inspection of cellular details as listed in Box 45.5 . The operator should ascertain whether the lesion is (1) cystic (true cyst or pseudocyst) and benign or malignant or (2) solid (hepatocellular or nonhepatocellular) and benign or malignant. The diagnostic algorithms for evaluation of cystic and solid lesions of the liver are provided in Boxes 45.6 and 45.7 , respectively.

    Box 45.5

    Evaluation of Cytohistologic Features of Aspirates of Focal Liver Lesions

    • Pattern recognition (low power)

      • Cellularity

      • Architectural features

      • Cellular composition

      • Background

    • Cellular recognition (medium to high power)

      • Size of cells

      • Shape of cells

      • Spatial relationship (e.g., degree of cohesion, crowding, polarity)

      • Cytoplasm, nucleus, nucleus-to-cytoplasm ratio

      • Inclusions, intracytoplasmic and intranuclear

      • Pigments

      • Vasculature

      • Background

    Box 45.6

    Algorithm for Diagnosing Cystic Lesions of the Liver

    • I.

      Cystic lesion with epithelial lining

      • A.

        Cuboidal or low columnar epithelium: solitary bile duct cyst, fibropolycystic disease, and obstructive dilatation of bile duct

      • B.

        Ciliated epithelium: ciliated foregut cyst

      • C.

        Biliary, mucinous, or oncocytic (with or without papillae)

        • 1.

          With ovarian-like stroma

          • a.

            Mucinous cystic neoplasm with low-, intermediate- or high-grade intraepithelial neoplasia

          • b.

            Mucinous cystic neoplasm with associated invasive carcinoma

        • 2.

          Without ovarian-like stroma

          • a.

            Biliary intraductal papillary neoplasm with low-, intermediate-, or high-grade intraepithelial neoplasia

          • b.

            Biliary intraductal papillary neoplasm with an associated invasive carcinoma

      • D.

        Intrahepatic cholangiocarcinoma associated with cystic change, arising from malignant transformation of preexisting cystic disease, or associated with cystically dilated bile ducts

      • E.


    • II.

      Cystic lesion without epithelial lining

      • A.

        Neoplastic (including tumor-like lesions)

        • 1.

          Cavernous hemangioma

        • 2.

          Mesenchymal hamartoma

        • 3.

          Cystic degeneration in benign or malignant tumors

        • 4.

          Undifferentiated embryonal sarcoma

      • B.


        • 1.

          Laminated wall: hydatid cyst

        • 2.

          Inflammation and necrosis: pyogenic, fungal, or amebic abscess, granulomas, necrotizing eosinophilic granuloma, hydatid cyst

        • 3.

          Hemorrhagic cyst: cystic hematoma

    Modified from Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010.

    Box 45.7

    Algorithm for Diagnosing Solid Lesions of the Liver

    • Hepatocellular appearance

      • Focal fatty change

      • Large regenerative nodule

      • Dysplastic nodule (low or high grade)

      • Siderotic nodule (regenerative, dysplastic)

      • Focal nodular hyperplasia

      • Hepatocellular adenoma

      • Hepatocellular carcinoma, variants and special types

      • Hepatoblastoma

      • Hepatocellular and glandular appearance

      • Combined hepatocellular and cholangiocarcinoma

    • Nonhepatocellular appearance

      • Glandular pattern: bile duct hamartoma, bile duct adenoma (peribiliary gland hamartoma), intrahepatic cholangiocarcinoma, combined hepatocellular-cholangiocarcinoma, metastases

      • Squamous, including adenosquamous, pattern: Intrahepatic cholangiocarcinoma, metastases

      • Mucinous pattern: mucinous cystic neoplasm, intrahepatic cholangiocarcinoma, metastases

      • Papillary pattern: intraductal papillary neoplasm, intrahepatic cholangiocarcinoma, metastases

      • Clear cell pattern: angiomyolipoma, metastases (renal cell carcinoma, adrenocortical carcinoma)

      • Oncocytic cell pattern: angiomyolipoma, metastases (renal cell carcinoma, adrenocortical carcinoma), melanoma

      • Small cell pattern: neuroendocrine tumor, lymphoma, metastases (small cell carcinoma, lobular carcinoma of breast, melanoma), inflammatory pseudotumor

      • Large cell pattern: neuroendocrine carcinoma, metastases (undifferentiated carcinoma)

      • Spindle cell pattern: cavernous hemangioma, infantile hemangioma, solitary fibrous tumor, inflammatory pseudotumor, angiomyolipoma, gastrointestinal stromal tumor, sarcomatoid carcinoma (including primary liver carcinomas and metastatic sarcomatoid renal cell carcinoma), sarcoma (primary and metastatic, including angiosarcoma, Kaposi sarcoma, carcinosarcoma, hepatobiliary rhabdomyosarcoma, synovial sarcoma and leiomyosarcoma)

      • Giant cell pattern: sarcomatoid or giant cell carcinoma (primary liver carcinomas and metastases), sarcoma (primary and metastases)

      • Others: nodular hematopoiesis, epithelioid hemangioendothelioma, germ cell tumors (teratoma, yolk sac tumor)

  • 4.

    Evaluate ancillary studies. The initial cytomorphologic impression is often crucial because the small amount of material may limit the utility of immunohistochemical and other ancillary tests.

  • 5.

    Correlate all previous steps. Clinicopathologic correlation is mandatory to arrive at a final definitive diagnosis. An “indeterminate” diagnosis may be rendered for very-well-differentiated hepatocellular nodules. Information obtained from all of the previous steps, including a complete immunohistochemical workup, may help to establish a generic morphologic diagnosis for nonhepatocellular lesions but not provide the specific organ of origin.

Box 45.4

Integrative Approach to the Evaluation of Liver Aspirates

  • Evaluate clinical information

  • Evaluate radiologic information

  • Evaluate cytohistologic findings

  • Evaluate ancillary studies

  • Correlate all previous steps

Cytohistology of the Liver

Normal Morphology

Aspirate smears of normal liver typically show a polymorphous cell population dominated by hepatocyte s, occurring singly in short rows or small clusters and intermingling with scattered bile duct epithelial cells and sparse sinusoidal endothelial cells and Kupffer cells ( Fig. 45.1, A ). Normal hepatocytes are large, polygonal cells with abundant granular cytoplasm and a centrally placed, round nucleus with a well-delineated nuclear membrane, granular chromatin pattern, and distinct nucleolus. Hepatocytes normally exhibit variations in cell and nuclear size (i.e., sibling polymorphism). The nucleus-to-cytoplasm ratio (N : C ratio) is approximately 1 : 3. Bile duct epithelial cells are smaller than hepatocytes and appear as flat, monolayered, honeycomb sheets of glandular epithelium (see Fig. 45.1, B ). They may also reveal an on-edge picket-fence arrangement or small acinar structures. The cells have minimal pale cytoplasm and equidistant, round to oval, bland nuclei without nucleoli. Bile duct epithelium can be differentiated from bile ductular epithelium.


Normal hepatocytes and bile duct epithelium. A, The polygonal hepatocytes occur in narrow cords and exhibit mild polymorphism with ample granular cytoplasm; a central, round nucleus; well-delineated nuclear membrane; granular chromatin; and a distinct nucleolus. The nucleus-to-cytoplasm ratio is about 1 : 3. The small bile duct epithelial cluster consists of uniform cells with oval nuclei and indistinct cytoplasm (Papanicolaou stain). B, Bile duct epithelium from a larger duct displays a flat, monolayered, honeycomb sheet of glandular cells with nuclear palisading. The cells have minimal, pale cytoplasm and evenly spaced, regular, oval, bland nuclei without nucleoli (Papanicolaou stain).

Elongated endothelial cells and comma-shaped Kupffer cells are almost indistinguishable from each other, especially when they appear as nuclear streaks. The thickness of liver cords can be appreciated in large sheets of cells and in fragments of liver parenchyma by focusing on the nuclear streaks in different planes of magnification ( Fig. 45.2 ).


Normal liver parenchyma. A, Fragment of liver parenchyma with jagged edges shows narrow cords of hepatocytes, nuclear streaks, and a portal tract (Papanicolaou stain). B, Nuclear streaks represent Kupffer or endothelial cells sandwiched between hepatocytes and highlighting the narrow width of the cell cords (Papanicolaou stain).


Lipofuscin is a fine, golden, granular, relatively nonrefractile pigment with Papanicolaou stain and is black with Giemsa stain ( Fig. 45.3 ). This predominantly perinuclear pigment is common in aspirates of adult livers, and its absence in the context of a mass lesion is considered suspicious for a hepatocellular neoplasm. One potential diagnostic pitfall is that lipofuscin stains similar to melanin with Fontana-Masson stain, and the sample may be mistaken for metastatic melanoma.


Lipofuscin pigment appears as nonrefractile, black granules located in the perinuclear cytoplasm of non-neoplastic hepatocytes (May-Grünwald-Giemsa stain).

Bile pigment varies in color, texture, size, and density, but it is best recognized by its coarse, irregular, rather amorphous, nonrefractile appearance. In Giemsa-stained preparations, bile appears as a purplish-black pigment within the cytoplasm of hepatocytes or as ropey strands within bile canaliculi ( Fig. 45.4 ). Hall stain may be used to confirm the pigment as bile.


Bile pigment is seen as purplish-black, ropey strands within bile canaliculi and a few black droplets within the cytoplasm of non-neoplastic hepatocytes in a patient with cholestasis (May-Grünwald-Giemsa stain).

Iron or hemosiderin may be present in hepatocytes, bile duct epithelial cells, and Kupffer cells as a coarse, golden-brown, refractile pigment with the Papanicolaou stain and brown-black with the Giemsa stain ( Fig. 45.5 ). Malignant hepatocytes typically lose their ability to retain iron. In the setting of hemochromatosis, Perl (Prussian blue) stain is a helpful ancillary tool to highlight nonstaining tumor cells.


Hemosiderin (iron) pigment appears as coarse, golden-brown, refractile granules within the cytoplasm of non-neoplastic hepatocytes (Papanicolaou stain).


Steatosis is common in the liver, and the examiner should be aware of focal fatty changes. Cytologically, fat may be a single, large, intracytoplasmic vacuole in a cell with an eccentric nucleus (i.e., macrovesicular steatosis) or multiple, small vacuoles in a cell with a central nucleus (i.e., microvesicular steatosis) ( Fig. 45.6 ). Fat is best appreciated in Giemsa-stained preparations, which often reveal abundant oil globules in the background as a result of ruptured hepatocytes.


Macrovesicular steatosis. Non-neoplastic hepatocytes show large, intracytoplasmic fat vacuoles pushing the nucleus to one side of the cell cytoplasm (Papanicolaou stain).


Liver abscess formations are suspected radiologically by the characteristic double target sign on CT scans. The most common is pyogenic abscess, in which case aspiration is performed for tissue confirmation, culture, and drainage. Smears are dominated by acute inflammatory cells and cellular debris ( Fig. 45.7 ). Cultures are helpful for identification of bacterial organisms. Special stains, such as Gram stain, are not usually helpful, but uniquely characteristic organisms may be readily identified on smears. For example, Actinomyces has sulfur granules ( Fig. 45.8 ).


Pyogenic abscess. Abundant neutrophils and cellular debris show golden-brown bile pigment (Papanicolaou stain).


Abscess caused by Actinomyces . The fibrillar, star-shaped sulfur granules are characteristic of this organism (Papanicolaou stain).

Smears from suspected fungal abscesses should be stained with Gomori methenamine silver and periodic acid–Schiff (PAS) stains. Amebic abscesses tend to be paucicellular with abundant amorphous granular debris, and trophozoites are rare. Necrotizing eosinophilic granulomas contain abundant eosinophils and possibly Charcot-Leyden crystals. Parasitic or fungal organisms should be sought ( Fig. 45.9 ).


Necrotizing eosinophilic granuloma. Neutrophils, eosinophils, and Charcot-Leyden crystals are evident (May-Grünwald-Giemsa stain).

A potential diagnostic pitfall is that necrotic tumors may be associated with fever, simulating abscesses clinically and radiologically; or they may become secondarily infected. If clinically warranted, aspiration cytology is recommended to avoid delay in instituting appropriate therapy.

Hydatid disease leads to cyst formation, which may become secondarily infected (see “ Cystic Lesions of the Liver ”). Echinococcosis is usually ruled out with clinical and imaging studies and the findings of a negative test result for specific echinococcal antibodies by serum enzyme immunosorbent assay performed before percutaneous needle aspiration. In the event that a hydatid cyst is aspirated, the pathologist should search for protoscolices or hooklets of Echinococcus granulosus in the fluid or pus ( Fig. 45.10 ).

FIGURE 45.10

Hydatid cyst. The fluid contains single refractile hooklets or, rarely, intact echinococcal protoscolices (May-Grünwald-Giemsa stain).

Granulomatous inflammation may be caused by fungal or acid-fast organisms, but the presence of granulomas is not necessarily diagnostic of an infection. Cytologically, granulomas are composed of clusters of epithelioid histiocytes that have oval to elongated, sometimes twisted nuclei and visible but indistinct cytoplasm. Multinucleated giant cells may be present ( Fig. 45.11 ). The characteristics of the necrotic background should also be evaluated. Gomori methenamine silver, PAS, and Ziehl-Neelsen stains may be performed on smears but are easier to perform on tissue sections.

FIGURE 45.11

Tuberculous granuloma. A multinucleated Langhans giant cell has a horseshoe-shaped arrangement of the nuclei (May-Grünwald-Giemsa stain).

Inflammatory pseudotumors are potential clinical, radiologic, and cytohistologic pitfalls because they mimic tumors. They may be lymphoplasmacytic, fibrohistiocytic, xanthogranulomatous, or granulomatous in nature ( Fig. 45.12 ). Activated lymphoid cells may be mistaken for lymphomas, atypical reactive hepatocytes for HCC, atypical reactive biliary epithelium for adenocarcinoma, atypical reactive stroma for sarcoma, and foamy histiocytes for amebic trophozoites. Immunoglobulin G4 (IgG4)–related disease may rarely manifest as a fibroblastic mass with lymphoplasmacytic infiltrates, eosinophils, IgG4-positive plasma cells, dense fibrosis of large bile ducts, and obliterative phlebitis.

FIGURE 45.12

Lymphoplasmacytic-type inflammatory pseudotumor. A, Aspirate smears are dominated by lymphocytes and plasma cells, with occasional spindle-shaped fibroblasts and multinucleated foreign body giant cells (Papanicolaou stain). B, Cell block shows a heavy lymphoplasmacytic infiltrate with a granulation tissue background (hematoxylin and eosin stain).

Nodular hematopoiesis is a rare diagnostic pitfall. Hematopoietic cells (especially megakaryocytes) may mimic inflammatory or malignant cells when perceived out of context.

Cystic Lesions of the Liver

The type of cyst contents should be evaluated because the presence of mucin is a helpful diagnostic clue. The next step is to establish the presence and type of epithelial lining and whether it is neoplastic or malignant. Box 45.6 provides a diagnostic algorithm for cystic lesions of the liver.

Cystic Lesions with an Epithelial Lining

Bile Duct Cyst, Simple Hepatic Cyst, and Fibropolycystic Disease

In cases of bile duct cyst, simple hepatic cyst, and fibropolycystic disease, the fluid may contain isolated cells or scant strips or sheets of cuboidal to low columnar epithelium without cytologic atypia ( Fig. 45.13 ).

FIGURE 45.13

Solitary bile duct cyst. Flat honeycomb sheet of cuboidal epithelium with no cytologic atypia (Papanicolaou stain).

Ciliated Foregut Cyst

Aspirates of foregut cysts are characterized by ciliated columnar cells and detached ciliated tufts. The background usually contains amorphous debris and rare macrophages. The differential diagnosis includes cystic neoplasms.

Mucinous Cystic Neoplasm and Intraductal Papillary Neoplasm

Mucinous cystic neoplasms and intraductal papillary neoplasms have overlapping cytomorphologic features. The cytodiagnosis may indicate a benign cyst, papillary neoplasm, or adenocarcinoma. FNAB alone cannot differentiate the various types of hepatobiliary cysts. Generic terms such as cystic mucinous neoplasm or neoplastic mucinous cyst may be applied if imaging studies are not available for correlation.

Mucinous cystic neoplasms typically occur as single or multiloculated, mucinous, epithelial-lined cysts surrounded by ovarian-type stroma. The cyst fluid may be watery or viscous. Diagnostic aspirates likely contain degenerated cuboidal to columnar epithelial cells with bland nuclear features ( Fig. 45.14 ). The neoplastic epithelial cells may be arranged singly, on edge, in sheets, or as small papillary tufts. The background usually shows mucin with chronic inflammatory cells, histiocytes, and debris. The degree of cellularity varies and tends to increase with higher grades of intraepithelial neoplasia. Stromal components are not usually present. With malignant transformation, features of adenocarcinoma with or without mucin and cellular debris are often evident. The definitive diagnosis requires correlation with clinical information, imaging studies, and histopathologic confirmation of ovarian-type stroma surrounding the cyst. The cyst fluid may be assayed for carcinoembryonic antigen and CA 19-9 to distinguish neoplastic from non-neoplastic liver cysts ( Box 45.8 ).

FIGURE 45.14

Mucinous cystic neoplasm. Mucinous glandular epithelium and foamy histiocytes predominate the contents of this benign hepatic cyst (cell block, hematoxylin and eosin stain).

(From Sidawy MK, Syed ZA. The Liver in Fine Needle Aspiration Cytology: A Volume in the Foundations in Diagnostic Pathology . Edinburgh: Churchill Livingstone; 2007.)

Box 45.8

Mucinous Cystic Neoplasm

  • Degenerated mucin-secreting cuboidal to columnar epithelium with bland nuclear features; arranged singly, on edge, in sheets or as small papillary tufts

  • Background usually shows mucin with chronic inflammatory cells, histiocytes, and debris

  • Mesenchymal stromal components are usually absent

  • Variable cellularity, depending on grades of intraepithelial neoplasia

  • Features of adenocarcinoma seen with malignant transformation

  • Assay of cyst fluid for carcinoembryonic antigen and CA 19-9

Biliary intraductal papillary neoplasm is a fusiform or cystic (unilocular or multilocular) luminal dilation in communication with the biliary tract. The affected intrahepatic bile ducts are typically filled with a noninvasive papillary or villous biliary neoplasm covering delicate fibrovascular stalks, and mucin may be seen. Aspirates are typically hypercellular, comprising broad and often double-layered sheets of ductal cuboidal or columnar epithelium with a distinctive three-dimensional, complex-branching papillary configuration ( Fig. 45.15 ). The sheets of cells do not form a honeycomb pattern but are crowded. Phenotypes include pancreaticobiliary, intestinal, gastric, and oncocytic forms. The epithelium shows intracytoplasmic mucin vacuoles and occasional signet ring cells. The nuclei show variable abnormalities. Psammoma bodies may be identified. Intraductal papillary neoplasm with associated invasive carcinoma has the highest degree of cellularity and pleomorphism ( Box 45.9 ).

FIGURE 45.15

Biliary intraductal papillary neoplasm. A, Delicate, branching, finger-like fibrovascular stalks are lined by three-dimensional, double-layered (crowded) sheets of cuboidal epithelium (Papanicolaou stain). B, Histologic section shows a complex branching papillary tumor, which would have been located within a cystically dilated duct (hematoxylin and eosin stain).

Box 45.9

Biliary Intraductal Papillary Neoplasm

  • Hypercellular smears

  • Broad, double-layered sheets of ductal columnar epithelium with three-dimensional, complex-branching papillae

  • Pancreaticobiliary, intestinal, gastric and oncocytic phenotypes

  • Crowded sheets of cells with variable nuclear atypia

  • Intracytoplasmic mucin vacuoles, including few signet ring cells

  • Psammoma bodies

  • Features of adenocarcinoma seen with malignant transformation


Metastatic papillary carcinomas of the pancreas and ovary can simulate intraductal papillary neoplasms. Smears may contain numerous finger-like fibrovascular stalks lined by cuboidal or columnar epithelium with cytologic atypia.

Cystic Lesions without an Epithelial Lining

Non-neoplastic Cysts

Aspirates of non-neoplastic cysts typically reveal an abundant amount of turbid, brown fluid with inflammatory cells, macrophages, fibrin, debris, and bile or hematoidin pigment. The fluid lacks lining epithelial cells but may contain benign cells from surrounding liver parenchyma. The differential diagnosis includes inflammatory/infectious cysts, cystic hematomas, as well as true cysts and cystic neoplasms. Secondary bacterial infection may produce cyst fluid that contains abundant neutrophils and proteinaceous background debris. However, the presence of a neoplastic lining epithelium or background mucin excludes the diagnosis of a non-neoplastic cyst.

Neoplastic Cysts and Tumor-like Lesions

Cavernous Hemangioma

Cavernous hemangiomas are usually asymptomatic, and they are usually diagnosed incidentally during the workup for other conditions, such as during the process of staging a malignancy, and they can be difficult to distinguish from metastasis radiologically. Hemorrhagic aspirates are often considered unsatisfactory. The nondiagnostic appearance of blood with loose rather than dense fibrous connective tissue and few or no background hepatocytes raises the possibility of a hemangioma in the proper clinical setting ( Fig 45.16 ). Histologic material is crucial in establishing a specific diagnosis ( Box 45.10 ).

FIGURE 45.16

Cavernous hemangioma. A, Scanty clumps of loose fibrous connective tissue are seen in the blood (May-Grünwald-Giemsa stain). B, Histologic section shows large, irregular, interconnecting endothelial-lined vascular spaces separated by loose connective tissue septa (hematoxylin and eosin stain).

Box 45.10

Cavernous Hemangioma

  • Bloody with scant cellularity on smears

  • Loose connective tissue; usually few to no hepatocytes

  • Smears commonly nondiagnostic; specific diagnosis depends more on cell block pattern

Mesenchymal Hamartoma

Aspirates of mesenchymal hamartomas are obtained mainly in the pediatric population, with rare exceptions, and usually show clusters of epithelial and mesenchymal or spindle-shaped cells with bland-appearing nuclei admixed with loose connective tissue ( Fig 45.17 ). However, aspiration cytology rarely enables a definitive diagnosis, and because hepatoblastomas or malignant mesenchymal tumors are difficult to exclude confidently, cytology is of limited value ( Box 45.11 ).

FIGURE 45.17

Mesenchymal hamartoma. A, Clusters of epithelial and spindle-shaped mesenchymal cells with bland nuclei are held together by myxoid matrix material (May-Grünwald-Giemsa stain). B, Histologic section shows lobulated islands of loose myxoid matrix containing misshapen ductal structures and mesenchymal cells (Masson trichrome stain).

Box 45.11

Mesenchymal Hamartoma

  • Hypocellular smears

  • Spindle-shaped cells with bland nuclei

  • Loose myxoid matrix with bile ductlike epithelial clusters

  • Cytology of limited value in establishing a definitive diagnosis

Cystic Degeneration in a Benign or Malignant Tumor

Solid tumors may undergo central necrosis and cavitation, simulating cysts radiologically. A necrosis-associated tumor should raise the suspicion of an abscess. Necrosis is more likely to occur in malignant lesions, such as squamous cell carcinomas, neuroendocrine tumors, and metastases from colorectal adenocarcinomas and nonkeratinizing undifferentiated carcinoma in the nasopharynx. The diagnostic cells may be obscured by the process.

Undifferentiated Embryonal Sarcoma

Although most undifferentiated embryonal sarcomas appear ultrasonographically as solid lesions, CT and MRI imaging may detect a low-attenuation mass with a cystic appearance. Most cystic structures result from liquefactive necrosis and blood clots; however, true cystic spaces may also occur. Aspirates recapitulate the histologic pattern of the tumor. Smears are usually composed of spindle cells and myxoid tissue, intermixed with pleomorphic cells ranging from small round cells to larger multinucleated giant cells. Giant cells have bizarre nuclei and massively deranged chromatin structure. They contain intracytoplasmic vacuoles and are AFP negative, PAS positive, but diastase-resistant hyaline globules ( Fig. 45.18 ); extracellular globules may also be present. Immunostaining for α 1 -antitrypsin, α 1 -antichymotrypsin, and carcinoembryonic antigen is positive in tumor cells. The cytologic differential diagnoses include rhabdomyosarcoma , hepatoblastoma, undifferentiated pleomorphic sarcoma, NOS (so-called malignant fibrous histiocytoma), and poorly differentiated HCC ( Box 45.12 ).

FIGURE 45.18

Undifferentiated embryonal sarcoma. A, Smears are composed of anaplastic and multinucleated tumor giant cells displaying bizarre nuclei and a deranged chromatin structure (Papanicolaou stain). B, Tumor cells may also contain periodic acid–Schiff (PAS)–positive, diastase-resistant intracytoplasmic globules (PAS with diastase digestion).

Box 45.12

Undifferentiated Embryonal Sarcoma

  • Hypercellular smears

  • Large, pleomorphic anaplastic cells with multinucleated giant cells and atypical spindle cells

  • Intracytoplasmic globules: periodic acid–Schiff positive, diastase resistant

Solid Lesions of the Liver

Hepatocellular Appearance

Benign Hepatocellular Nodules

Benign hepatocellular nodules, which can be non-neoplastic or neoplastic, such as focal fatty changes, large regenerative nodules, dysplastic nodules, focal nodular hyperplasia, and hepatocellular adenomas, are discussed together because they share common cytologic features, including fatty changes ( Box 45.13 ). Unfortunately, it is not always possible to distinguish these entities on the basis of smear cytology alone. They all can mimic well-differentiated HCC.

Box 45.13

Regenerative, Dysplastic, and Benign Neoplastic Hepatocellular Nodules

  • Hepatocytes arranged in jagged irregular clusters, small clusters, short rows, and singly (depending on regenerative, dysplastic, or neoplastic nature)

  • No peripheral endothelium

  • Clusters rarely have transgressing endothelium (except for neoplastic aspirates)

  • Reactive hepatocytes show sibling polymorphism with normal nucleus-to-cytoplasm (N : C) ratio (1 : 3) and frequent binucleation

  • Sporadically placed large, atypical cells with mild nuclear pleomorphism of nuclear size but normal N : C ratio (in dysplastic hepatocytes with large cell change)

  • Small, uniformly monotonous hepatocytes with increased N : C ratio and nuclear crowding (in dysplastic hepatocytes with small cell change)

  • Variably prominent nucleoli but without macroeosinophilic nucleoli

  • Cytoplasm usually abundant (except in small cell change) and granular but may show a fatty change, lipofuscin pigment, or iron deposition

  • Bile duct epithelium present (except in neoplastic aspirates)

  • Bile ductular epithelium and stromal fragments, indicative of hepatocellular-interface restoration, may be present (except in neoplastic aspirates)

  • Reticulin stain shows retention of one- to two-cell-thick hepatic cords on cell block

A focal fatty change may simulate a mass lesion radiologically. Aspirates are composed of a polymorphous population of enlarged, fat-laden, non-neoplastic hepatocytes intermingled with bile duct epithelial clusters. Oil globules may be seen in the background on air-dried smears.

Aspirates from large regenerative nodules are similar to those from cirrhosis, in which a polymorphous liver parenchymal population shows evidence of hyperplasia and hepatocellular-interface restoration (i.e., bile ductular epithelium and stromal fragments). Hyperplastic hepatocytes occur in two-cell-thick cords and exhibit slight polymorphism and binucleated forms. Normal bile duct epithelial clusters should be differentiated from bile ductular epithelial cells, which appear as curved, narrow, double-stranded rows of cells with overlapping, dark, oval nuclei; scant or absent cytoplasm; and a high N : C ratio. Nuclear disarray may be disconcerting. Ductules can be seen emanating from the jagged edges of sizeable parenchymal fragments ( Fig. 45.19 ). Stroma may be seen in the background. The presence of ductules should raise the diagnostic threshold for a malignant process.

FIGURE 45.19

Large regenerative nodule. Reactive hepatocytes in irregularly shaped clusters are associated with a curved bile ductule emanating from the hepatocellular-stromal interface. The ductule consists of a double row of closely apposed, overlapping, small, darkly stained, oval nuclei with absent cytoplasm (May-Grünwald-Giemsa stain).

Hepatocellular atypia, such as large cell and small cell changes (e.g., dysplasia), are considered neoplastic precursor lesions and may be detected in aspirates from cirrhotic livers. Hepatocytes with large cell changes show corresponding cellular and nuclear enlargement and mild nuclear atypia; but the normal N : C ratio (i.e., one to three or less) is maintained ( Fig. 45.20 ). Hepatocytes with small cell changes are small and monotonous, with a subtle increase in the N : C ratio. The nuclear size is similar to that of normal hepatocytes, but there is less cytoplasm, imparting an impression of nuclear crowding ( Fig. 45.21 ).

FIGURE 45.20

Hepatocytes with large cell changes. There is cell and nuclear enlargement. The nucleus-to-cytoplasm ratio is maintained at about 1 : 3. Compare with normal hepatocytes in the bottom right side of the image (May-Grünwald-Giemsa stain).

FIGURE 45.21

Hepatocytes with small cell changes. Monotonous, small hepatocytes exhibit decreased cytoplasm, an increased nucleus to cytoplasm ratio, and an impression of nuclear crowding. Compare with two clusters of normal hepatocytes in the vicinity (Papanicolaou stain).

Aspirates of low-grade dysplastic nodules show hepatocytes that exhibit large cell changes, whereas those from high-grade dysplastic nodules show hepatocytes with small cell changes. Dysplastic hepatocytes tend to occur singly or in narrow cords, usually one to two cells thick. Transgressing endothelium is not a feature. It is almost impossible to distinguish a small cell change from a well-differentiated or early HCC. The key to recognizing a large cell change as benign is the sporadic placement of these cells in a background of otherwise reactive-appearing hepatocytes and accompanied by bile ductal or ductular epithelium and stroma. Availability of histologic material for immunohistochemistry is invaluable.

Patients with cirrhosis without iron overload can accumulate iron within regenerative or dysplastic nodules, which are called siderotic nodules . Siderotic dysplastic nodules are considered to be premalignant, whereas siderotic regenerative nodules are a marker for severe viral or alcoholic cirrhosis. Iron-free foci in patients with genetic hemochromatosis are likely to be malignant.

Focal nodular hyperplasia is characterized by a proliferation of hepatocytes surrounding a central scar containing blood vessels and bile ducts. A brisk ductular reaction is often seen at the hepatocellular-stromal interface. Aspirates typically contain a polymorphous population of cells, but this varies. Hyperplastic hepatocytes abound in one- to two-cell-thick cords. Bile duct epithelium is usually evident ( Fig. 45.22 ). The presence of ductular epithelium supports the benign nature of this lesion, but this feature can be mistaken for adenocarcinoma if it is the dominant component of the aspirate. A possible diagnostic pitfall is mistaking reactive stroma for a spindle cell neoplasm. A characteristic geographic immunostaining pattern is seen with the use of glutamine synthetase. Without radiologic demonstration of a central scar, it may not be possible to differentiate focal nodular hyperplasia from large regenerative nodules on smear cytology, because both show features of regeneration.

FIGURE 45.22

Focal nodular hyperplasia. A, Hyperplastic hepatocytes are present with ductules, which are represented by small, darkly stained, oval nuclei, emanating from the hepatocellular-stromal interface (Papanicolaou stain). B, Histologic section shows a brisk ductular reaction at the hepatocellular-stromal interface from the edge of a central scar (hematoxylin and eosin stain).

Aspirates of a hepatocellular adenoma are hypercellular and typically contain well-differentiated hepatocytes occurring in one- to two-cell-thick cords ( Fig. 45.23 ). There is no significant atypia. Transgressing endothelium is common, but peripheral endothelium is lacking. The tumor cells are polygonal and have moderate granular cytoplasm. Some cells display fatty or clear cell changes and bile or lipofuscin pigment. Bile duct epithelium is absent. The reticulin framework is usually well preserved. CD34, which highlights capillarization of the sinusoids in HCC, can also positively stain adenomas, particularly in the periseptal areas. This may be a diagnostic pitfall in assessing small, fragmented liver core specimens and cell block preparations. Glypican 3 staining should be focal and weak at best. The diagnosis requires clinical correlation. Chapter 55 provides more information on immunohistochemical markers of adenomas in tissue sections.

FIGURE 45.23

Hepatocellular adenoma. The hypercellular smear contains narrow cords (as many as three cells thick) of hepatocytes displaying mild sibling polymorphism but without significant cytologic atypia (Papanicolaou stain).

A nodule-in-nodule lesion occurs when an HCC subnodule develops within a parent dysplastic or regenerative nodule. Representative FNAB samples may be a problem because of the focality of proliferative clones within these nodules. Classic aspirates reveal more than one population of lesional hepatocytes, including malignant hepatocytes and dysplastic or hyperplastic hepatocytes in the background ( Fig. 45.24 ). The presence of biliary epithelial cells varies.

FIGURE 45.24

The nodule-in-nodule lesion is composed of a well-differentiated hepatocellular carcinoma arising within a large regenerative nodule. Notice the two populations of hepatocytes. Well-defined malignant hepatocytes from the subnodule exhibit mild pleomorphism, dense cytoplasm, and an increased nucleus-to-cytoplasm ratio. They are located among pale, hyperplastic hepatocytes with a normal nucleus-to-cytoplasm ratio from the parent nodule (Papanicolaou stain).

Primary Malignant Hepatocellular Neoplasms

Hepatocellular Carcinoma

HCCs exhibit marked heterogeneity in differentiation, histologic patterns (i.e., trabecular-sinusoidal, pseudoacinar, and solid types), and cell morphology. The World Health Organization (WHO) classification of HCC lists the classic type, several variants, and special types. Sampling limitations of the FNAB technique and cytohistologic challenges in the face of this diversity are recognized. Most tumors show relatively good hepatic preservation and obvious malignant features. However, diagnostic dilemmas exist at both ends of the spectrum—cytologic features of malignancy are lacking at the well-differentiated end and resemblance to hepatocytes is lacking at the poorly differentiated end. The cytomorphologic features of HCC are summarized in Box 45.14 . The cytologic nuclear grading of HCC into well-, moderately, and poorly differentiated is outlined in Boxes 45.15 through 45.17 .

Box 45.14

Cytologic Findings of Fine-Needle Aspiration Biopsy for Hepatocellular Carcinoma


  • Hypercellular

  • Uniformly granular smear pattern

Epithelial cohesiveness

  • Cellular cohesion is the rule (tendency to dispersion at ends of cytomorphologic spectrum)

  • Arborizing tonguelike projections or balls of tumor cells with peripheral endothelium


  • Trabecular-sinusoidal pattern (indicated by the peripheral endothelium)

  • Pseudoacinar pattern (implied by the rosette-like gaps in cellular aggregates)

Cellular characteristics

  • Monomorphous population of abnormal hepatocytes

  • Better-differentiated tumors are characterized by polygonal cells with well-defined cell borders, ample granular cytoplasm, round central nuclei with well-delineated nuclear membrane, prominent nucleoli, and granular chromatin.

  • The nucleus-to-cytoplasm ratio increases in proportion to the nuclear grade.

  • Nuclear pleomorphism correlates with irregular nuclear contours, mitoses, and multinucleated tumor giant cells.

  • Atypical naked hepatocytic nuclei

Cellular inclusions

  • Intracytoplasmic bile droplets or canalicular or pseudoacinar bile plugs

  • Intracytoplasmic fat vacuoles

  • Intracytoplasmic glycogen

  • Intracytoplasmic hyaline globules, pale bodies, and Mallory bodies

  • Intranuclear (cytoplasmic) inclusions

Vascular component

  • Peripheral endothelium

  • Transgressing, arborizing, and central endothelium

Background elements

  • Normal or reactive hepatocytes

  • Bile duct epithelial clusters

  • Hemorrhagic, necrotic background

Box 45.15

Cytologic Findings of Fine-Needle Aspiration Biopsy for Well-, Moderately, and Poorly Differentiated Hepatocellular Carcinoma

  • Well-differentiated hepatocellular carcinoma

    • Tumor cells resemble hepatocytes in size, shape, and nuclear and nucleolar appearances.

    • The nucleus-to-cytoplasm (N : C) ratio is slightly higher.

    • Mitoses are exceptional.

  • Moderately differentiated hepatocellular carcinoma

    • Cells remain similar to hepatocytes in general appearance, with the following distinctions.

    • The N : C ratio is moderately high.

    • Round to ovoid nuclei show a moderate degree of pleomorphism.

    • Nucleoli are prominent, and mitoses are easily identifiable.

  • Poorly differentiated hepatocellular carcinoma

    • Resemblance to hepatocytes is lacking.

    • Tumor cells exhibit marked pleomorphism, less cytoplasm, very high N : C ratio, thin nuclear membranes with irregular nuclear contours, hyperchromasia, and numerous mitoses.

    • Multinucleated tumor giant cells are easily identifiable.

Box 45.16

Well-Differentiated Hepatocellular Carcinoma

  • On low-power microscopy, the smear pattern shows trails of smooth-edged, arborizing clusters of thickened trabeculae with peripheral endothelium (pathognomonic)

  • On low power, the smear pattern shows many loosely cohesive sheets of hepatocytes with transgressing vessels (highly suspect finding)

  • Monotonous, uniform hepatocytic cell population with subtle malignant features

  • Pseudoacinar formation in cell clusters

  • Nucleus-to-cytoplasm ratio higher than in normal hepatocytes (>1 to 3)

  • Macroeosinophilic nucleoli

  • Reduced number of binucleated cells

  • Background free of bile duct epithelial cells

  • Reticulin stain demonstrates loss of the normal one- to two-cell-thick hepatic cord architecture

  • Iron stain fails to stain tumor cells in hemochromatosis

  • α-Fetoprotein is helpful if positive but often is not

  • Novel markers, such as glypican 3, glutamine synthetase, and heat shock protein 70, are helpful if two of three show positivity

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 31, 2019 | Posted by in GENERAL | Comments Off on Diagnostic Cytology of the Liver

Full access? Get Clinical Tree

Get Clinical Tree app for offline access